Concept DHA By US Pharmaceutical Corporation Overview & Drug Interactions

Check For Interactions With Concept DHA

Supplement: Concept DHA by US Pharmaceutical Corporation

Concept DHA Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Concept DHA by US Pharmaceutical Corporation

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 30
UPC/BARCODE 352747621308

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
25 mg
Vitamin C (ascorbic acid) 28% 21%
Vitamin B1
2 mg
Thiamin 167% 143%
Vitamin B2
3 mg
Riboflavin 231% 188%
ProAscorb C
1.8 mg
Proprietary Blend 11% 10%
Vitamin B6
25 mg
Vitamin B6 1471% 1250%
Folic Acid
1 mg
Folate 250% 167%
Vitamin B12
12.5 mcg
Vitamin B12 521% 446%
Biotin
300 mcg
Biotin 1000% 857%
Pantothenic Acid
5 mg
Vitamin B5 (Pantothenic Acid) 100% 71%
Iron
35 mg
Iron 194% 130%
Ferrous Fumarate
17.5 mg
Iron
Polysaccharide Iron Complex
17.5 mg
Iron
Magnesium
5 mg
Magnesium 1% 1%
Zinc
10 mg
Zinc 91% 77%
Copper
2 mg
Copper 222% 154%
Fish Oil
310 mg
Fish Oil -- --
Omega-3 Fatty Acids
200 mg
Omega-3 -- --
Docosahexaenoic Acid
156 mg
DHA (Docosahexaenoic Acid) -- --
Eicosapentaenoic Acid
39 mg
EPA (Eicosapentaenoic Acid) -- --
ProAscorb C
43 mg
Proprietary Blend (Combination) -- --
Calcium Ascorbate
0 NP
Calcium Ascorbate
Ascorbic Acid
0 NP
Vitamin C (ascorbic acid)
Ascorbyl Palmitate
0 NP
Vitamin C (ascorbyl palmitate)
Niacinamide Ascorbate
0 NP
Niacinamide ascorbate
Xylitol
0 NP
Xylitol
Sodium Ascorbate
0 NP
Sodium Ascorbate
Magnesium Ascorbate
0 NP
Magnesium ascorbate
Lysine Acetate
0 NP
Lysine
Citrus Bioflavonoids
0 NP
Flavonoid (mixture)
Potassium Ascorbate
0 NP
Potassium ascorbate
Sodium Pyrophosphate
0 NP
sodium pyrophosphate
D-Ribofuranose
0 NP
Ribose
L-Cysteine
0 NP
Cysteine
Glutathione
0 NP
Glutathione
Hesperidin
0 NP
Hesperidin

Other Ingredients:
Beeswax
Hypromellose
Titanium Oxide
FD&C Red 40


Label Statments:


General Statements
- 52747-0621-30 Rx only
- Consult package literature for full prescription information.
- Lift here for full prescription information
- "An increase in tolerability is observed with the formulation and is believed to occur as the result of distributing the total iron content in the composition among compounds that provide iron to the patient's blood stream via two different mechanisms. The ferrous salts are readily absorbed in the upper gut, by direct dissolution and absorption of the ferrous iron by the bloodstream. However, the iron available from PIC is absorbed in the lower gut, via an active protein transport mechanism"
- Clinical Studies: Picinni, L.-Ricciotti, M. 1982. Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemias. PANMINERVA MEDICA-EUROPA MEDICA, Vol. 24, No. 3, pp.213-220 (July-September 1982).
- How supplied: Concept DHA are red maroon opaque Vcaps capsules printed in white with "Concept DHA" on the cap and "US" logo on the body. Packed in child-resistant cap and light resistant bottle of 30 capsules (52747-0621-30). The listed product number is not a National Drug Code. Instead, US Pharmaceutical Corporation has assigned this product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and healthcare insurance computer systems.
Formula
- Prenatal Multivitamin & Mineral Supplement capsules with Omega-3 fatty acids - DHA & EPA
- Prenatal Multivitamin & Mineral Supplement capsules with Omega-3 fatty acids - DHA & EPA
- Ferrous Fumarate and Polysaccharide Iron Compex (PIC): All Concept products include a unique patented source of iron, e.g. Ferrous Fumarate and Polysaccharide Iron Complex (U.S. Patent No: 11/243,043 pending).
Precautions
- You should contact your healthcare provider for medical advice about adverse events. To report a serious adverse event, contact US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036. Marketed by US Pharmaceutical Corporation.
- Caution: Rx only.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
- Contraindications: Concept DHA is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. It is also contraindicated in patients suffering from pernicious anemia as folic acid may obscure its signs and symptoms.
- Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Precautions: Folic acid in doses above 0.1 mg - 0.4 mg daily may obscure the signs and symptoms of pernicious anemia, in the hematological remission can occur while neurological manifestations remain progressive. Overdose: Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300-mg/kg body weight.
- When overdoses are ingested by children, severe reactions, including fatalities, have resulted.
- Packed in child-resistant cap and light resistant bottle of 30 capsules (52747-0621-30).
Formulation
- Manufactured with Vcaps capsule shells.
- Manufactured in a FDA registered facility in the USA.
- Indications: Concept DHA is a prenatal supplement designed to improve the nutritional status of women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Concept DHA may also be used to improve the nutritional status of women before conception.
- Folic Acid: Folic Acid is one of the most important hematopoietic agents necessary for proper regeneration of the blood-forming elements and their function. Additionally, folic acid increases jejunal glycolytic enzymes and is involved in the desaturation and hydroxylation of long-chain fatty acids in the brain. A deficiency in folic acid results in megaloblastic anemia.
Storage
- Store at room temperature 15 degrees to 30 degrees C (59 degrees to 86 degrees F) and dry place.
Brand IP Statement(s)
- Patent Numbers: USA: 5,626,883; Mexico MX/a/2008/004461; Singapore: 200802623-9 and other countries.
- Vcaps and the Vcaps Logo are trademarks used under license.
Suggested/Recommended/Usage/Directions
- Dosage and Administration: Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Brand Information

See all products by this brand

Manufacturer
Name US Pharmaceutical Corporation
Street Address P.O. Box 360465
City Decatur
State GA
ZipCode 30036

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.